Photodynamic therapy against cervical intraepithelial neoplasia by talaporfin sodium
Phase 3
Recruiting
- Conditions
- cervical intraepithelial neoplasia (CIN1 - CIN3)
- Registration Number
- JPRN-UMIN000021386
- Lead Sponsor
- Murakami Hirotake
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
The case which has no reported complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The curative ratio of photodynamic therapy by talaporfin sodium against CIN is confirmed at 2 months and 5 months after PDT.
- Secondary Outcome Measures
Name Time Method The side effects of photodynamic therapy by talaporfin are confirmed.